Status:
COMPLETED
18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
Lead Sponsor:
Université Catholique de Louvain
Collaborating Sponsors:
Fonds National de la Recherche Scientifique
Conditions:
Paget's Disease of Bone
Eligibility:
All Genders
Phase:
NA
Brief Summary
18 F-fluoride Positron emission tomography (PET) is able to demonstrate and quantify the metabolic activity locally in the skeleton (1). This technique should, therefore, also be able to demonstrate a...
Detailed Description
I. Background of the subject: Paget's disease of bone is a condition characterized by a focal exuberant increase in bone remodeling, resulting in a number of important architectural abnormalities, po...
Eligibility Criteria
Inclusion
- Patients with a monostotic form of PDB (as attested by plain X-rays and 99mTc MDP bone scintigraphy)
- Bone pain linked to Paget's disease itself
Exclusion
- Bisphosphonate therapy within the year prior to the study
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00306046
Start Date
February 1 2002
End Date
March 1 2006
Last Update
March 22 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatology, Molecular Imaging and Experimental Radiotherapy departments, Saint-Luc University Hospital, Catholic University of Louvain
Brussels, Belgium, 1200